Amer, 1980, Cytologica, 45, 715, 10.1508/cytologia.45.715
Anderson, 1983, Environ Health Perspect, 47, 239, 10.1289/ehp.8347239
Armitage, 1955, Biometrics, 11, 374, 10.2307/3001775
Au, 1980, Cytogenet Cell Genet, 26, 108, 10.1159/000131432
Basler, 1981, Anesthesiology, 55, 143, 10.1097/00000542-198108000-00010
Bidwell, 1975, Mutat Res, 31, 314, 10.1016/0165-1161(75)90110-7
Bruce, 1979, Can J Genet Cytol, 21, 319, 10.1139/g79-036
Charles, 1978, Toxicol Lett, 2, 225, 10.1016/0378-4274(78)90071-1
Chen, 1982, Environ Mutagen, 4, 621, 10.1002/em.2860040513
Coate, 1979, J Environ Pathol Toxicol, 2, 209
Davring, 1977, Hereditas, 85, 123, 10.1111/j.1601-5223.1977.tb00959.x
(1981): Activity of 27 coded compounds in the RL1 chromosome assay. In (eds): “Evaluation of Short-Term Tests for Carcinogens (Prog Mutat Res 1).” New York: Elsevier Biomedical, pp 570–579.
Dean, 1985, Mutat Res, 153, 57, 10.1016/0165-1110(85)90005-3
De Oca-Luna, 1984, Mutat Res, 141, 183, 10.1016/0165-7992(84)90094-0
Dulout, 1982, Mutat Res, 105, 413, 10.1016/0165-7992(82)90186-5
Duprat, 1980, IRCS Med Lib Compend, 8, 182
Emerit, 1983, Mutat Res, 110, 327, 10.1016/0027-5107(83)90149-5
Esser, 1981, Hum Genet, 56, 345, 10.1007/BF00274690
(1981): Effects of 20 coded chemicals on sister chromatid exchange frequencies in cultured Chinese hamster cells. In (eds): “Evaluation of Short-Term Tests for Carcinogens (Prog Mutat Res 1).” New York: Elsevier Biomedical, pp 538–550.
Galloway, 1985, Environ Mutagen, 7, 1, 10.1002/em.2860070102
, , , , (1987): Effects of high osmotic strength on chromosome aberrations, sister-chromatid exchanges and DNA strand breaks, and the relation to toxicity. Mutation Res. (in press).
Goto, 1978, Chromosoma, 66, 351, 10.1007/BF00328535
Grant, 1979, Mutat Res, 65, 83, 10.1016/0165-1110(79)90001-0
Green, 1975, Toxicol Appl Pharmacol, 33, 161
Green, 1977, FDA Bylines, 6, 292
Gu, 1981, Ann Genet, 24, 105
Habedank, 1982, Hum Genet, 61, 71, 10.1007/BF00291338
Hashem, 1976, Afr J Med Sci, 5, 155
Heneen, 1966, J Cell Biol, 31, 543, 10.1083/jcb.31.3.543
Herbold, 1982, Teratogen Carcinogen Mutagen, 2, 91, 10.1002/1520-6866(1990)2:1<91::AID-TCM1770020110>3.0.CO;2-Z
Hite, 1979, Environ Mutagen, 1, 383, 10.1002/em.2860010411
Husum, 1983, Mutat Res, 113, 264, 10.1016/0165-1161(83)90083-3
Ikeda, 1980, Toxicol Lett, 5, 251, 10.1016/0378-4274(80)90068-5
Inoue, 1982, Mutat Res, 101, 305, 10.1016/0165-1218(82)90123-9
(1983): “Chromosome Aberration Test In Vitro.” Tokyo: Realize, Inc.
Ishidate, 1981, GANN Monogr Cancer Res, 27, 95
Ivett, 1983, Environ Mutagen, 5, 450
Jenssen, 1980, Mutat Res, 75, 191, 10.1016/0165-1110(80)90014-7
Jorgenson, 1978, Mutat Res, 53, 124, 10.1016/0165-1161(78)90482-X
Kaina, 1985, Mutat Res, 142, 49, 10.1016/S0165-7992(85)80012-9
Kasamaki, 1982, Mutat Res, 105, 387, 10.1016/0165-7992(82)90181-6
, , , , , (1980): Results of recent studies on the relevance of various short-term screening tests in Japan. In , , (eds): “The Predictive Value of Short-Term Screening Tests in Carcinogenicity Evaluation (Appl Meth Oncol 3).” New York: Elsevier/North Holland, pp 253–267.
Kelly-Garvert, 1973, Mutat Res, 17, 223, 10.1016/0027-5107(73)90170-X
(1981): Micronucleus test on 21 compounds. In (eds): “Evaluation of Short-Term Tests for Carcinogens (Prog Mutat Res 1).” New York: Elsevier Biomedical, pp 698–704.
Lamb, 1981, J Toxicol Environ Health, 8, 825, 10.1080/15287398109530118
Lang, 1982, Mutat Res, 92, 243, 10.1016/0027-5107(82)90227-5
Linnainmaa, 1983, Mutat Res, 113, 276, 10.1016/0165-1161(83)90102-4
Majerfeld, 1978, Mol Gen Genet, 159, 203, 10.1007/BF00270894
Margolin, 1983, Environ Mutagen, 5, 705, 10.1002/em.2860050509
Margolin, 1985, Environ Mutagen, 7, 48, 10.1002/em.2860070810
Margolin, 1986, Environ Mutagen, 8, 183, 10.1002/em.2860080203
Mast, 1982, Environ Mutagen, 4, 340
Morimoto, 1983, Mutat Res, 119, 355, 10.1016/0165-7992(83)90185-9
Morris, 1982, Mutat Res, 105, 163, 10.1016/0165-7992(82)90006-9
(1981): Mutagenic activity of 20 coded compounds in chromosome aberration/sister chromatid exchanges assay using Chinese hamster ovary (CHO) cells. In (eds): “Evaluation of Short-Term Tests for Carcinogens (Prog Mutat Res).” New York: Elsevier Biomedical, pp 551–559.
Nicholas, 1979, Mutat Res, 67, 167, 10.1016/0165-1218(79)90128-9
Nishio, 1981, J Toxicol Environ Health, 8, 939, 10.1080/15287398109530128
Obe, 1979, Drug Alcohol Depend, 4, 91, 10.1016/0376-8716(79)90044-9
, , , (1981): In vivo SCE analysis of 20 coded compounds. In (eds): “Evaluation of Short-Term Tests for Carcinogens (Prog Mutat Res 1).” New York: Elsevier Biomedical, pp 673–681.
Parodi, 1983, Mutat Res, 108, 225, 10.1016/0027-5107(83)90122-7
Pentiah, 1980, Indian J Exp Biol, 18, 869
(1981): Evaluation of the sister chromatid exchange method in mammalian cells as a screening system for carcinogens. In (eds) “Evaluation of Short-Term Tests for Carcinogens (Prog Mutat Res 1).” New York: Elsevier Biomedical, pp 560–569.
Perry, 1974, Nature, 251, 156, 10.1038/251156a0
Raff, 1980, Mutat Res, 78, 51, 10.1016/0165-1218(80)90025-7
Reggiani, 1980, J Toxicol Environ Health, 6, 27, 10.1080/15287398009529828
Riedel, 1984, Phenytoin, primidone and phenobarbital. Mutat Res, 38, 71, 10.1016/0165-1218(84)90087-9
, (1981): Mutagenic activity of 41 compounds in the in vivo micronucleus assay. In (eds): “Evaluation of Short-Term Tests for Carcinogens (Prog Mutat Res 1).” New York: Elsevier Biomedical, pp 686–697.
Schlegel, 1983, Mutat Res, 113, 481, 10.1016/0165-1161(83)90002-X
Schmid, 1983, Mutat Res, 113, 304, 10.1016/0165-1161(83)90150-4
Seiler, 1978, Mutat Res, 58, 353, 10.1016/0165-1218(78)90029-0
Sen, 1985, Cancer Res, 45, 2230
Sieber, 1978, Teratology, 18, 31, 10.1002/tera.1420180107
Stetka, 1977, Chromosoma, 63, 21, 10.1007/BF00292939
Stevenson, 1971, Ann Rheum Dis, 30, 487, 10.1136/ard.30.5.487
Stich, 1981, Mutat Res, 90, 355, 10.1016/0165-1218(81)90058-6
Stiller, 1982, Mutat Res, 97, 437, 10.1016/0165-1161(82)90035-8
Tenchini, 1983, Environ Mutagen, 5, 73, 10.1002/em.2860050109
Thust, 1980, Activity in clastogenicity and SCE assays and aberration kinetics in Chinese hamster V79-E cells. Mutat Res, 79, 239
(1981): Activity of coded compounds in the micronucleus test. In (eds): “Evaluation of Short-Term Tests for Carcinogens (Prog Mutat Res 1).” New York: Elsevier Biomedical, pp 705–711.
Tunek, 1982, Chem-Biol Interact, 39, 129, 10.1016/0009-2797(82)90116-8
Valadaud-Barrieu, 1983, Mutat Res, 119, 55, 10.1016/0165-7992(83)90037-4
Vogel, 1978, Mutat Res, 53, 279, 10.1016/0165-1161(78)90362-X
von Vormittag, 1979, Arzneim-Forsch, 29, 1163
Wassom, 1978, Mutat Res, 47, 141, 10.1016/0165-1110(77)90001-X
White, 1979, Anesthesiology, 50, 426, 10.1097/00000542-197905000-00010
Wilmer, 1981, Environ Mutagen, 3, 627, 10.1002/em.2860030605
Yamamoto, 1980, Mutat Res, 71, 127, 10.1016/0027-5107(80)90012-3